Mayne Pharma Group (ASX:MYX) said the Australian Pharmaceutical Benefits Scheme (PBS) approved the reimbursement of oral contraceptive Nextstellis, according to a Monday filing with the Australian bourse.

Nextstellis will be listed on the PBS General Schedule from October, the filing said.

Shares rose nearly 1% in morning trade on Monday.